WINTON GROUP Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$288,000
-72.1%
13,621
-80.4%
0.02%
-38.2%
Q3 2020$1,032,000
-42.1%
69,611
-42.6%
0.03%
-26.1%
Q2 2020$1,783,000
+96.1%
121,190
+56.5%
0.05%
+91.7%
Q1 2020$909,000
-30.8%
77,444
+38.6%
0.02%
+33.3%
Q4 2019$1,313,000
+144.1%
55,867
+92.0%
0.02%
+200.0%
Q3 2019$538,000
+152.6%
29,098
+233.5%
0.01%
+50.0%
Q1 2019$213,0008,7240.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders